Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
36.2M
-
Shares change
-
-1.6M
-
Total reported value, excl. options
-
$145M
-
Value change
-
-$7.66M
-
Put/Call ratio
-
0.32
-
Number of buys
-
38
-
Number of sells
-
-56
-
Price
-
$3.99
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q2 2022
127 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2022.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.2M shares
of 60M outstanding shares and own 60.36% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (9.9M shares), VANGUARD GROUP INC (2.44M shares), CITADEL ADVISORS LLC (2.32M shares), Prosight Management, LP (1.99M shares), Verition Fund Management LLC (1.9M shares), EAGLE ASSET MANAGEMENT INC (1.51M shares), Knoll Capital Management, LLC (1.5M shares), MILLENNIUM MANAGEMENT LLC (1.24M shares), GOLDMAN SACHS GROUP INC (1.18M shares), and 683 Capital Management, LLC (1M shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.